Product Code: ETC8833819 | Publication Date: Sep 2024 | Updated Date: Jun 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The acute myeloid leukemia (AML) market in the Philippines is gaining visibility due to rising cancer diagnoses and improved disease awareness. AML affects both adults and older populations, with treatment options concentrated in specialized hospitals. Government health initiatives are slowly expanding access to cancer treatment, although socioeconomic disparities still influence patient outcomes. Better diagnostic tools and oncology infrastructure are critical to supporting this market.
The acute myeloid leukemia (AML) market is growing steadily as healthcare facilities improve diagnostic accuracy and therapeutic options. Increasing incidence, especially among elderly populations, is driving demand for advanced treatments and supportive care. Collaboration between private and public sectors in oncology care is enhancing patient access to novel AML therapies.
The acute myeloid leukemia (AML) market in the Philippines is burdened by late detection and a lack of comprehensive cancer care pathways. Access to bone marrow transplantation remains highly restricted, and supportive care resources like transfusion services are inconsistent. The high mortality rate is exacerbated by socioeconomic disparities in treatment access.
The acute myeloid leukemia (AML) market in the Philippines presents growth opportunities driven by improved diagnostic capabilities and therapeutic innovations. Investments in hematology centers that specialize in blood cancers and stem cell transplantation are crucial. Companies that develop or import targeted therapies, such as FLT3 inhibitors and hypomethylating agents, will find an expanding customer base. Supportive care infrastructure for managing chemotherapy side effects is also in high demand.
The government recognizes acute myeloid leukemia (AML) as a major hematologic malignancy and integrates its management within the national cancer control plan. Policies focus on enhancing diagnostic accuracy, increasing access to chemotherapy, and supporting bone marrow transplantation programs. The DOH collaborates with academic institutions and cancer centers to strengthen AML patient registries and clinical care standards.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Acute Myeloid Leukemia Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Acute Myeloid Leukemia Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Acute Myeloid Leukemia Market - Industry Life Cycle |
3.4 Philippines Acute Myeloid Leukemia Market - Porter's Five Forces |
3.5 Philippines Acute Myeloid Leukemia Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Philippines Acute Myeloid Leukemia Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Philippines Acute Myeloid Leukemia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Philippines Acute Myeloid Leukemia Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Philippines Acute Myeloid Leukemia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Acute Myeloid Leukemia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Acute Myeloid Leukemia Market Trends |
6 Philippines Acute Myeloid Leukemia Market, By Types |
6.1 Philippines Acute Myeloid Leukemia Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Myeloblastic, 2021- 2031F |
6.1.4 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Promyelocytic, 2021- 2031F |
6.1.5 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Myelomonocytic, 2021- 2031F |
6.2 Philippines Acute Myeloid Leukemia Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.3 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.2.4 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.2.5 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Hormone Therapy, 2021- 2031F |
6.2.6 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Philippines Acute Myeloid Leukemia Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Acute Myeloid Leukemia Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Philippines Acute Myeloid Leukemia Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Philippines Acute Myeloid Leukemia Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Philippines Acute Myeloid Leukemia Market Import-Export Trade Statistics |
7.1 Philippines Acute Myeloid Leukemia Market Export to Major Countries |
7.2 Philippines Acute Myeloid Leukemia Market Imports from Major Countries |
8 Philippines Acute Myeloid Leukemia Market Key Performance Indicators |
9 Philippines Acute Myeloid Leukemia Market - Opportunity Assessment |
9.1 Philippines Acute Myeloid Leukemia Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Philippines Acute Myeloid Leukemia Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Philippines Acute Myeloid Leukemia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Philippines Acute Myeloid Leukemia Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Philippines Acute Myeloid Leukemia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Acute Myeloid Leukemia Market - Competitive Landscape |
10.1 Philippines Acute Myeloid Leukemia Market Revenue Share, By Companies, 2024 |
10.2 Philippines Acute Myeloid Leukemia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |